{"id":"W4200447938","doi":"10.1093/ofid/ofab466.1072","title":"877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes","year":2021,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rilpivirine; Medicine; Population; Internal medicine; Regimen; Human immunodeficiency virus (HIV); Viral load; Virology; Antiretroviral therapy; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004352109,0.00024885,0.0004541641,0.0001588431,0.0007658263,0.0005243614,0.0003575227,0.0003248645,0.004037655],"category_scores_gemma":[0.001650404,0.0001402852,0.0003748278,0.0006078528,0.0003913332,0.0003832366,0.0003940449,0.0004419802,0.0006803715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001617672,"about_ca_system_score_gemma":0.003869007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04166517,"about_ca_topic_score_gemma":0.07797311,"domain_scores_codex":[0.9988681,0.0006648865,0.00004831993,0.00008680739,0.0001930669,0.0001389197],"domain_scores_gemma":[0.9985294,0.0002411407,0.0002144824,0.00007660678,0.000346997,0.0005912793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1676624,0.02036655,0.2417128,0.0009545551,0.00132383,0.0003858132,0.001546069,0.001025389,0.01626658,0.0009768357,0.03541321,0.5123661],"study_design_scores_gemma":[0.05008716,0.1486016,0.7108259,0.0003067759,0.001528233,0.000770695,0.001417233,0.002270549,0.008270874,0.0005926718,0.07523432,0.00009395049],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803641,0.004586023,0.0004497317,0.0007289901,0.00006475584,0.0006424137,0.002000567,0.00004641549,0.01111697],"genre_scores_gemma":[0.9877051,0.001695493,0.001465745,0.001257047,0.00009933746,0.0005910203,0.003051087,0.00002003256,0.004114971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04166517,"threshold_uncertainty_score":0.08284527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01139738430684836,"score_gpt":0.3088464482955847,"score_spread":0.2974490639887364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}